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Abstract.  Although renal hypertrophy is often as- 
sociated with the progressive loss of renal function, 
the mechanism of hypertrophy is poorly understood. 
In both primary cultures of rabbit proximal tubules 
and NRK-52E cells (a renal epithelial cell line), trans- 
forming growth factor ~1  (TGF/~) converted epidermal 
growth factor (EGF)-induced hyperplasia into hyper- 
trophy.  TGFB did not affect EGF-induced increases in 
c-fos mRNA abundance or cyclin E protein abun- 
dance, but inhibited EGF-induced entry into S, G2, 
and M phases.  EGF alone increased the amount of 
hyperphosphorylated (inactive) pRB;  TGF/~ blocked 
EGF-induced pRB phosphorylation, maintaining pRB 
in the active form. To determine the importance of ac- 
tive pRB in TGFB-induced hypertrophy, NRK-52E 
cells were infected with SV40 large T antigen (which 
inactivates pRB and related proteins and p53),  HPV16 
E6 (which degrades p53),  HPV16  E7 (which binds 
and inactivates pRB and related proteins), or both 
HPV16  E6 and E7.  In SV40 large T antigen expressing 
clones, the magnitude of EGF  +  TGF~induced 
hypertrophy was inhibited and was inversely related to 
the magnitude of SV40 large T antigen expression. In 
the HPV16-infected cells, EGF  +  TGF/3-induced 
hypertrophy was inhibited in E7- and E6E7-expressing, 
but not E6-expressing cells. These results suggest a re- 
quirement for active pRB in the development of EGF 
+  TGF~-induced renal epithelial cell hypertrophy. We 
suggest a model of renal cell hypertrophy mediated by 
EGF-induced entry into the cell cycle with TGF/3- 
induced blockade at G~/S, the latter due to maintained 
activity of pRB or a related protein. 
ENAL tubular hypertrophy occurs in a number of con- 
ditions,  including  diabetes  mellitus,  loss  of renal 
mass,  protein feeding,  chronic metabolic  acidosis, 
and potassium deficiency (13). In many of these conditions 
the hypertrophy has been postulated  to cause progressive 
loss of renal function (6, 53).  Despite its importance, the 
mechanism by which tubular hypertrophy occurs is largely 
unknown.  One  possible  mechanism is  that  hypertrophy 
represents an aborted cell cycle, with cells entering the G, 
phase and initiating protein synthesis and growth, but failing 
to progress into S phase. This hypothesis would predict that 
events associated with entrance into G, would be the same 
in hyperplastic  and hypertrophic processes,  but that events 
associated  with  the transition  between G~  and  S  phases 
would be different, with only hyperplastic cells progressing 
into S phase. 
pRB, the product of the retinoblastoma  gene, plays a key 
role in regulating the GdS transition  (2, 7, 21). Active (hy- 
pophosphorylated)  pRB  inhibits  G,/S  progression;  hyper- 
phosphorylation  inactivates pRB, allowing progression into 
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S phase. Transforming growth factor B (TGFB) exerts an an- 
tiproliferative effect in a number of  cells (36), which is medi- 
ated in part by inhibition  of pRB phosphorylation  (main- 
tenance of active pRB)  and blockade of the cell cycle at 
G,/S (32). In addition,  TGFB has been implicated in renal 
tubular and vascular smooth muscle cell hypertrophy (17, 42, 
46, 52). In the present study, a model of hypertrophy in renal 
proximal tubule epithelial cells was developed to test the hy- 
pothesis that TGFB-mediated hypertrophy is coupled to cell 
cycle processes.  Primary cultures of rabbit proximal tubule 
cells developed hyperplasia in response to epidermal growth 
factor (EGF), hypoplasia in response to TGFBI, and hyper- 
trophy in response to the combination of EGF + TGF/~. The 
ability of TGF/~ to convert EGF-induced hyperplasia to hy- 
pertrophy was related to inhibition to pRB phosphorylation 
and the maintenance of active pRB or a related protein. 
Materials and Methods 
Chemicals were purchased from Sigma Chemical Co. (St. Louis, MO), ex- 
cept as indicated below. Dulbecco's modified Eagle's medium and Ham's F12 
culture media, fetal bovine serum, and trypsin/EDTA were from GIBCO 
BRL (Gaithersburg, MD); transferrin was from Miles Pentex (Kankakee, 
IL); penicillin and streptomycin were from BioWhitaker,  Inc., M. A. Bio- 
products (Walkersville, MD); type 1 collagenase was from Boehringer Mann- 
heim Corp. (Indianapolis, IN); culture dishes were from Corning Glass- 
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R&D System (Minneapolis, MN); Hoechst H33258 was from Calbiochem 
(La Jolla, CA); [3H]thymidine,  [3H]phenylalanine, and the ECL kit were 
from Amersham (Arlington Heights, IL); pRB immunoallinity purification 
kit and anti-pRB antibodies were from Santa Cruz Biotechnology (Santa 
Cruz, CA). 
Cell Culture 
Primary rabbit proximal tubule cultures were prepared as previously de- 
scribed (22). Briefly, 4-6-wk old New Zealand white rabbits were killed and 
renal cortex trimmed from the kidneys, sliced with a Stadie-Riggs tissue 
slicer, and incubated in 0.1% type i  collagenase for 40 rain at 37°C with 
moderate shaking. The resulting tissue suspension was centrifuged on an 
isosmotic 50% percoll gradient at 20,000 g for 30 rain (JA-20 rotor and J2- 
21M centrifuge; Beckman Instrs., Fullerton, CA). Tubules aspirated from 
the F4 fraction were resuspended and centrifuged to wash out the pereoll. 
The pellet was then diluted by culture media to achieve a concentration of 
3,000 tubules/ml and inoculated onto tissue culture dishes. Culture media 
consisted of a  i:1  mixture of DME and Ham's FI2 supplemented with 5 
#g/ml insulin, 50  nM hydrocortisone, 35  p,g/ml  transferrin, 29  nM  Na 
selenite, 20/~M ethanolamine, 1.5 mM L-glutamine, I00 U/mi penicillin, 
and  100  ~g/ml  streptomycin. 3%  fetal bovine serum was added to the 
medium for the first 3 d to facilitate cell attachment. Cells were grown to 
•80%  confluence and then rendered quiescent by the removal of insulin and 
hydrocortisone for 48 h before initiating the experimental protocols. 
NRK-52E cells (a rat kidney epithelial cell line) were obtained from the 
American Type Culture Collection (Rockville, MD) at passage 15, and pas- 
saged and grown in low glucose DME with 5% FCS. These cells were in- 
fected with a retroviral construct containing the SV40 large T antigen gene 
with tsA58 and U19 mutations, and a neomycin resistance gene, both in- 
serted into the vector pZIPSV(X)I (26, 27). For infection with HPV16 E6 
and E7, the retroviral construct consisted of HPV16 E6 and/or E7 genes and 
a neomycin resistance gene, both inserted into the vector PLXSN (24, 48). 
Control ceils were infected with the vector containing only the neomycin 
resistance gene. These constructs were infected into an amphntropic pack- 
aging cell line PA317. The packaging cells were allowed to reach confluency, 
the medium was removed, and fresh medium (10% FBS DME) placed on 
the PA317 cells for 16 h. The media was then removed from the packaging 
cells, filtered through a 0.4-p.m filter,  and placed on NRK-52E cells when 
20% confluent. The cells were exposed to the virus for 10 h, the viral media 
replaced with 5 % CS DME, and selection begun 48 h later with 400 p.g/ml 
G-418.  After 10 d  the G-418 dose was reduced to 200 p.g/ml for main- 
tenance. G-418 was removed at the time cells were plated for studies. SV40 
large T antigen clonal cell lines were established by limiting dilution. Cells 
plated for studies were rendered quiescent by the removal of serum for 48 h 
before initiating the experimental protocols. 
Mice transgenic for SV40  large T  antigen (Tg[SV40E]Bri7)  (1)  were 
killed by decapitation and the kidneys were removed, washed in ice cold 
PBS, decapsulated, and microdissected. Approximately I  mm of mouse 
proximal  convoluted tubule  (MPCT), I  mouse  proximal  straight tubule 
(MPST), and inner stripe of the outer medullary collecting duct (MMCD1 
and MMCD2) were washed in PBS and separately cultured in 24-well plates 
with a 1:1 mixture of Ham's F12 and low glucose DME supplemented with 
1.5 mM L-glutamine, 100 U/ml penicillin, I00/~g/rnl streptomycin, and 5% 
fetal bovine serum. Cells plated for studies (passages 5-20) were rendered 
quiescent at 50% confluence for 48 h before initiating the experimental pro- 
tocols. 
To determine SV40  large T  antigen expression, Western blotting was 
used. Cells were grown to confluence in 100-mm dishes, rinsed in PBS x 
2, and lysed at 4°C in 1 ml of RIPA buffer (1% NP-40, 0.4% deoxycholate, 
0.1% SDS, 150 mM NaC1, 50 mM Tris, pH 8.0) containing 2 mM EDTA, 
0.1 mg/ml PMSF, 2 txg/ml aprotinin, and 2/zg/ml leupeptin. The lysate was 
centrifuged at  12,000 g  for 10 rain at 4°C and the supernatant stored at 
-70°C. Equal amounts of protein, determined by Lowry (34), were loaded 
on a 6% polyacrylamide gel. Western blotting was performed as described 
below for pRB, using a  1:100 dilution of primary antibody (1:1 mixture of 
two monoclonal antibodies Pab416 and Pab419 [20]).  SV40 large T antigen 
expression was quantitated by scanning densitometry. Results are expressed 
as percent expression compared to the highest expressing clone. 
1. Abbreviations  used in this paper:  MMCD, mouse medullary collecting 
duct; MPCT, mouse proximal convoluted tubule; MPST, mouse proximal 
straight tubule. 
In general, all studies compared four groups: (a) control (with both EGF 
and TGFf31 vehicles); (b) EGE with TGFf~I vehicle; (c) TGFfil, with EGF 
vehicle; and (d) the combination of EGF and TGF/31. Recombinant human 
TGF/31 was reconstituted in 4 mM HCI containing 0.1% heat-treated BSA. 
Recombinant human EGF was reconstituted in PBS. Media were changed 
daily. In all studies, except those examining the dose response to TGF/31 or 
EGE TGF~31 was used at  10  -I° M  and EGF at 10  -s M. 
Measurement of Cell Protein, DNA, and Cell Size 
Primary cultures were grown in 6-well dishes and cell lines in  12-well 
dishes, washed with PBS, harvested with 0.25% trypsin and 1 mM EDTA 
for 30 min (primary cultures) or 0.05%  trypsin and 0.5 mM EDTA for 5 
min (cell lines), pelleted at 1,500 g for 5 min, and washed again with PBS. 
The final pellet was resuspended in 1 ml lysis buffer (50 mM Na2PO4, pH 
7.4) and the cells lysed on ice by repeated passage though a 27-gauge needle. 
The lysate was then aliquoted and stored at  -70°C for protein and DNA 
determination. The aliquots frozen for measuring DNA content contained 
1 mM EDTA. Protein was measured by Lowry (34). DNA was measured 
using  the  fluorescent compound  Hoechst H33258  in  an  SLM  8000(2 
fluorimeter (30). Cell hypertrophy was defined as an increase in the ratio 
of protein/DNA, determined in aliquots obtained from the same well. 
Cell size was obtained by measuring forward light scatter on an EPICS 
II profile analyzer. Cells were harvested and suspended in 0.25% trypsin/1 
mM EDTA.  Forward light scatter was measured on 8,000 to 12,000  cells, 
after gating to remove cellular debris. 
Measurement of  [3H]Thymidine and 
FH]Phenylalanine Incorporation 
Rates of DNA and protein synthesis were measured as rates of [3H]thymi- 
dine and  [3H]phenylalanine incorporation, respectively. To  measure the 
rate of phenylalanine incorporation, 2 p.Ci/well of [3H]phenylalanine  were 
added 8 h before harvest of cells grown in 12-well tissue culture plates. To 
harvest, cells were washed with PBS and protein precipitated with 0.5 
ml/well of 5 % TCA. After washing with distilled water to remove all unin- 
corporated labeled phenylalanine, proteins were solubilized with 0.5 ml of 
0.5 N NaOH/0.1%  Triton X-100 per well, and the resulting protein suspen- 
sion was counted in a scintillation counter (LS 3801; Beckman). Parallel 
wells for each experimental group were harvested and suspended in 0.25% 
trypsin/1 mM EDTA, and cells counted with a hemocytometer. Results are 
expressed as [3H]phenylalanine uptake/cell (cpm/cell). 
To measure the rate of thymidine incorporation, 1 /zCi/well of [3H]thy- 
midine was added 6 h before harvest of cells grown in a 96-well tissue cul- 
ture plate. Cells were harvested onto filter paper using a PHD cell harvester 
(Cambridge Technologies, Cambridge, MA), and filters counted in a scin- 
tillation counter. Parallel wells for each experimental group were harvested 
and suspended in 0.25%  trypsin/1 mM EDTA  and cells counted with a 
hemocytometer. Results are expressed as [3H]thymidine uptake/cell (cpm/ 
cell), 
Retinoblastoma (pRB) Protein Phosphorylation 
The proportion ofpRB in the hypo- or hyperphosphorylated form was deter- 
mined on SDS-PAGE by mobility shift (15, 32).  On Western blots, the 
hypophosphorylated species is detected as an apparent 105-kD protein and 
the hyperphosphorylated species as an apparent ll0-116-kD protein. Cells 
were rinsed with PBS, harvested on ice with cold lysis buffer (pRB ina- 
munoaflinity purification kit,  supplemented with 0.1  rng/ml PMSF, 0.66 
U/rnl aprotinin,  1 mM sodium orthovanadate, and 2/zg/mi leupeptin) by 
scraping with a rubber policeman, lysed by repeated passage through a 27- 
gauge needle, and centrifuged at 15,000 g for 20 min at 4°C. The superna- 
tant was incubated with agarose-conjugated mouse monoclonal pRB anti- 
bodies for 6 h. Bound protein was then eluted with pH 11.2 elution buffer 
(pRB immunoaffinity purification kit) and stored at  -70°C  for Western 
blotting. Samples were mixed with loading buffer (1% SDS, 10% glycerol, 
1%/3-mercaptoethanol, 5 % electrophoretic buffer), boiled for 5 min, elec- 
trophoresed on a 6 % polyacrylamide gel, electrophoretically transferred to 
nitrocellulose, and blotted using a polyclonal anti-pRB antibody at 1:50 di- 
lution (31). pRB bands were detected using ECL and exposed on Kodak 
X-Omat film for 3-15 s. The percentage ofpRB in the hyperphosphorylated 
form was quantitated by subtracting the amount of pRB in the hypophos- 
phorylated state from the local amount of pRB, using scanning densitome- 
try.  Results are expressed as the percent of total pRB in the hyperphos- 
phorylated (ppRB) form. 
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To measure cyclin E protein abundance samples were size fractionated on 
a 8.75 % polyacrylamide gel, and Western blotting performed with a 1:3,000 
dilution of primary antibody (rabbit anti-cyclin E) (a generous gift from Dr. 
James Roberts, Fred Hutchinson Cancer Institute, Seattle, WA). Cyclin E 
bands were detected using ECL  and abundance quantitated by scanning 
densitometry. 
c-fos mRNA Abundance 
Total cellular RNA was extracted using a  modification of the method of 
Chirgwin et al. (3, 37). Cultured cells were scraped in guanidium thiocya- 
hate solution (4 M guanidium thiocyanate, 0.5% N-lauroylsarcosine, 0.I M 
2- mercaptoethanol, and 25 mM sodium citrate [pH 7.0]), disrupted by gen- 
tle aspiration through a 22-gange needle twice, centrifuged through a 5.7 M 
CsCI cushion at 52,000 rpm for 2  h at 20°C  (Optima TLX: TL55 rotor; 
Beckman Instruments), and further purified by ethanol precipitation. Total 
RNA was size fractionated by agarose-formaldehyde gel electrophoresis and 
transferred to nylon filters (Genescreen-Plus; New England Nuclear, Bos- 
ton, MA) in 20x  SSC.  Prehybridization, hybridization, washing, and ex- 
posure to film were performed as described previously (3, 37). Radiolabeled 
probes were made by random primer using full-length c-fos and GAPDH 
cDNAs (5, 14). c- fos and GAPDH abundance were quantitated by scanning 
densitometry. 
Cell Cycle Analysis 
Ceils grown in 6-well culture dishes were harvested with 0.25 % trypsin/0.5 
mM EDTA, washed in PBS x  1 on ice, pelleted by centrifugation at 1,500 g 
for 5 rain at 4"C, and resuspended in 0.5 ml saline GM (8.0 gm/L NaCl, 
1.1 gm/L glucose, 0.4 gm/L KCI, 0.29 gm/L Nal-I2 PO4"7H20, 0.15 mg/L 
KH2PO4, 0.5 mM EDTA, pH 7.4). While vortexing gently, 1.5 ml ethanol 
was added slowly, and the cells were allowed to fix overnight at 40C in con- 
tainers wrapped tightly in foil (4, 45). The cells were then pelleted by cen- 
trifugation, resuspended in 250/~1 of I  mg/ml RNase A, allowed to sit for 
30 min at 37°C, repelleted by centrifugation, and resuspended in 200 t~l of 
50  pg/ml propidium iodide.  Ceils were analyzed on a  FACscan (Becton 
Dickinson, Mountain View,  CA) using Lysis II software. Cell cycle phase 
analysis was done using the CellFIT program (Becton Dickinson). 
Statistics 
All data are presented as mean +  SEM. Statistical significance was deter- 
mined by one-way ANOVA. Linear regression analysis was used to correlate 
SV40 large T  antigen expression with the magnitude of hypertrophy. 
Results 
EGF Induces Hyperplasia and TGFf31 
Induces Hypoplasia 
Initial  studies  were  performed  on  rabbit  proximal  tubule 
ceils  grown to  ~80%  confluence,  rendered  quiescent  for 
48 h  (see  Materials  and  Methods),  and  then  exposed  to 
EGF  00  -8 M),  TGF~  (10  -I° M),  the combination of EGF 
(10  -8 M)  +  TGF~I (10  -'° M), or vehicles for 48-96 h. Fig. 
1 shows the effect of these compounds on DNA content/well. 
EGF alone increased DNA content/well at all time points, 
consistent with a  mitogenic effect. TGF/31  alone decreased 
DNA content/well at all time points, consistent with an an- 
tiproliferative  effect.  At  48  and  72  h  the  combination  of 
EGF  +  TGF~I had little effect on DNA content/well, but at 
96 h  DNA content/well  was decreased. 
To confirm that the changes in DNA content/well repre- 
sented  changes  in  cell  proliferation,  and  not  cell  death, 
[~H]thymidine  incorporation  was  measured.  As  shown  in 
Fig. 2, EGF consistently increased, and TGF~I consistently 
decreased thymidine incorporation, confirming their hyper- 
plastic  and hypoplastic effects,  respectively.  The combina- 
tion of EGF  +  TGFffl increased thymidine incorporation at 
Figure I. Effect of EGF and/or TGF/31 on DNA content/well.  Pri- 
mary cultures of rabbit proximal tubule cells were exposed to EGF 
(10  -s M) and/or TGF/31 (10  -'° M) and/or vehicle for the indicated 
times.  DNA content/well  is plotted on the y-axis as a percent of 
control values (cells treated  with vehicles  only), n  =  18 at 48 h, 
n  =  24 at 72 and 96 h.  *  =  P <  0.01 vs. control. 
24 h, reflecting a predominant EGF effect, had no effect on 
thymidine incorporation at 48 h,  and decreased thymidine 
incorporation  at  72  h,  reflecting  a  predominant  TGF/31 
effect.  Since  these  cells  are  not entirely  quiescent  in  the 
absence of serum (indicated by a basal rate of thymidine in- 
corporation) the apparent  lag time in the TGF~I  effect on 
thymidine incorporation is probably due to the lack of syn- 
chronization of the cell population. 
EGF + TGF{31  Induces Cell Hypertrophy 
To determine whether these models were associated with cell 
hypertrophy, cell protein was measured, and the ratio of pro- 
tein/DNA calculated. As shown in Fig. 3, EGF alone had no 
effect on the ratio of protein/DNA, TGFffl alone induced a 
small increase in the ratio of  protein/DNA, and the combina- 
Figure 2. Effect of EGF and/or TGF~I on [3H]thymidine incorpo- 
ration/cell.  Cells were grown and treated as in Fig.  1. Thymidine 
incorporation is plotted on the y-axis as a percent of control values 
(cells treated  with vehicles  only), n  =  48 at 24 and 48 h, n  =  36 
at 72 h.  * =  P  <  0.05 vs. control, **  =  P  <  0.01 vs. control;  + 
=  P  <  0.01 vs. EGF alone. 
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Figure 3. Effect of  EGF and/or TGFBI on the ratio ofprotein/DNA. 
Cells were grown and treated as in Fig.  1. The ratio ofprotein/DNA 
is plotted on the y-axis as a percent of control values (cells treated 
with vehicles only), n  =  18 at 48 h, n  =  24 at 72 and 96 h. *  = 
P  <  0.05 vs. control; **  =  P  <  0.01 vs. control. 
tion of EGF  +  TGFB1 caused a progressive increase in the 
protein/DNA ratio.  Similar results were observed in NRK- 
52E  cells,  which  also hypertrophy  following  exposure  to 
EGF  +  TGFBI (ratio of protein/DNA increased by 44 and 
77 %  at 48 and 96 h,  respectively)  (data hot shown). 
To examine the dose dependence of the hypertrophic effect 
of EGF  +  TGFB1, studies were performed in which TGF~I 
concentration was varied between  10  -12 and  10  -l° M  while 
EGF concentration was held constant at  10  -s M,  and EGF 
concentration  was  varied  between  10  -9 and  10  -7 M  while 
TGFB1  concentration  was  held  at  10  -1° M.  When  TGFB1 
concentration was varied, the hypertrophic effect of TGFB1 
was not seen with 10  -~2 M  TGF~I, a 6% increase in the ra- 
tio of protein/DNA  was  seen  with  10-;;  M  TGFB1,  and a 
21%  increase  was  seen  with  10  -1° M  TGFB1.  In contrast, 
when EGF concentration was varied, similar increases in the 
ratio of protein/DNA were observed with EGF concentra- 
tions ranging from 10  -9 to 10  -~ M.  All further studies uti- 
lized  10  -l° M  TGF/ffl  and  10  -8 M  EGE 
The above effect of EGF  +  TGFB1  on the ratio  of pro- 
tein/DNA could be due to an effect on extracellular matrix 
protein accumulation, and not reflect a true increase in cell 
size (hypertrophy). To address this possibility flow cytome- 
try was used to measure mean forward light scatter, an index 
of cell size. Fig. 4 a, illustrates a representative experiment 
plotting cell number as a function of forward light scatter at 
72 h. The data was summarized in Fig. 4 b.  EGF alone had 
a small effect on mean forward light scatter between 48 and 
96 h, and TGFB1 alone had no effect. However, the combina- 
tion of EGF +  TGFB1 significantly increased mean forward 
light scatter at all time points. These studies confirm that the 
combination of EGF  +  TGFB1 is hypertrophic in proximal 
tubule cells. The small increase in mean forward light scatter 
seen with EGF alone is consistent with an increased number 
of cells in Gl,  S, and G2 phases as a  consequence of EGF- 
induced proliferation.  With TGFB1 alone the small increase 
in the protein/DNA ratio with no effect on cell size is proba- 
bly secondary to TGFBl:induced stimulation of extracellular 
matrix protein production, an effect that would be included 
Figure 4. Effect of EGF and/or TGFB1 on mean forward light scat- 
ter. Cells were grown and treated  as in Fig.  1. (,4) Representative 
tracing of relative cell number (plotted on the y-axis) as a function 
of forward light scatter  (plotted  on the x-axis) at 72 h. (B) Mean 
forward light scatter is plotted on the y-axis as a percent of control 
values (cells treated  with vehicles  only), n  =  15 per group.  *  = 
P  <  0.01 vs. control. 
in the protein/DNA,  but not the forward light scatter mea- 
surement. 
To examine  whether  the  increase  in  cell  size  was asso- 
ciated with an increase in protein  synthesis,  pH]phenylal- 
anine incorporation was measured.  Consistent with a mito- 
genie effect (parallel increases in DNA and protein content), 
EGF alone increased phenylalanine incorporation (Fig.  5). 
TGFBI alone had no effect on phenylalanine incorporation. 
The combination of EGF  +  TGFBI  profoundly increased 
phenylalanine incorporation. Thus, hypertrophy in the latter 
group was accompanied by an increase in protein synthesis. 
Taken together these studies demonstrate that in rabbit prox- 
imal tubule ceils EGF alone is hyperplastic, TGFBI alone is 
hypoplastic, and the combination ofEGF +  TGFB1 is hyper- 
trophic. 
EGF + TGF[J-induced Hypertrophy Involves G~ Arrest 
To determine the cell cycle phase of the hypertrophied cells 
propidiurn iodide labeling of  NRK-52E cells was assessed on 
the FACScan following 48 h exposure to EGF and/or TGFffl. 
As shown in Fig. 6, EGF alone increased, while TGFI~I alone 
decreased the percentage of cells in S/G2/M phases.  TGFI~I 
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dance. Northern blot. NRK-52E cells were rendered quiescent for 
48 h, and then exposed to vehicle alone (C), EGF (10  -8 M) (E), 
or EGF (10  -8 M) + TGF/~I ri0  -t° M) (TE) for the indicated times. 
Figure 5. Effect of EGF and/or  TGF/~I on [3H]phenylalanine in- 
corporation/cell.  Ceils  were  grown  and  treated  as  in  Fig.  1. 
Phenylalanine incorporation is plotted on the y-axis as a percent of 
control values (ceils treated with vehicles only), n =  18 per group. 
*  =  P < 0.01 vs. control. 
significantly inhibited EGF-induced entrance into S/GJM. 
Similar results were found in primary cultures of proximal 
tubule ceils (data not shown). Thus, in both cell types, EGF 
induced a shift into the S/GJM phases, which was blocked 
by TGF~. 
Failure to enter S/G2/M phases in the TGF/~-treated cells 
could be due to arrest in G~ or failure to enter G~. To ad- 
dress  this  the  effect of TGF/31 on  two  markers  of EGF- 
induced cell cycle entry was examined. As shown in Fig. 7, 
EGF  alone  induced  a  transient  increase  in  c-fos  mRNA 
abundance, that peaked at 15-30 min. TGF/~I  addition did 
not affect the c-fos increase, supporting the fact that TGF~I 
does not inhibit EGF-induced entrance into Gj. 
The next study examined the effect of EGF and/or TGF/~I 
on cyclin E protein abundance, that typically begins to rise 
Figure 6. Effect of EGF and/or TGF/31 on the percent of cells in 
S/G2/M phases  of the  cell cycle. NRK-52E cells  were  rendered 
quiescent  for 48  h  and then  treated  with  EGF (10  -8 M)  and/or 
TGF/31 (10  -~° M) for 48 h before harvest. Cell cycle phase analysis 
was performed as described in the Methods section. * =  P < 0.01 
vs. control;  #  =  P < 0.01 vs. EGF alone. 
in mid-Gt. Fig.  8 a, shows a Western blot at 48 h, while b 
summarizes  the  results  of four  experiments  in  NRK-52E 
cells.  Cyclin E protein abundance was increased following 
exposure to EGE  The combination of EGF  +  TGF/31 in- 
creased cyclin E  protein abundance to an extent similar to 
that seen with EGF alone, again suggesting that TGF/~ does 
not prevent entrance into G~. Taken together these results 
suggest that TGF~-mediated hypertrophy is associated with 
cells entering G~ but not progressing to S phase. 
TGF[31 Inhibits EGF-induced pRB Phosphorylation 
The next studies examined whether regulation of pRB phos- 
phorylation contributed  to  EGF  +  TGF/~-induced  hyper- 
trophy.  In  its  hypophosphorylated  state  pRB  is  active, 
inhibiting  progression  from GI  to  S  phase,  while  hyper- 
phosphorylated  pRB  is  inactive,  allowing  progression  to 
S phase (33, 39, 49). As described in Materials and Methods 
the  inactive,  hyperphosphorylated  form of pRB  migrates 
more slowly on protein gel electrophoresis than the active, 
hypophosphorylated form (15, 32).  As shown in Fig. 9,  in 
primary cultures of proximal tubule cells EGF alone induced 
a  time-dependent  increase  in  pRB  phosphorylation  when 
added to quiescent ceils, which was apparent as early as 6 h, 
and became maximal at 12 h. This allows cells to progress 
into S phase and undergo hyperplasia. 
To determine  if the  ability  of TGF/31 to  convert EGF- 
induced  hyperplasia to hypertrophy involves regulation of 
pRB phosphorylation, we examined the effect of TGF/~I  on 
EGF-induced  pRB  phosphorylation.  Fig.  10  a,  shows  a 
Western blot at 48 h, while b summarizes results of three ex- 
periments at 24-72 h in primary cultures of proximal tubule 
cells. EGF alone induced hyperphosphorylation, and TGF/Yl 
induced hypophosphorylation, although this latter effect did 
not  reach  statistical  significance.  TGFffl  inhibited  EGF- 
induced phosphorylation of pRB at 48 and 72 h.  The lack 
of effect at 24 h corresponds to the failure of TGF/31 to inhibit 
the  EGF-induced  increase  in  thymidine  incorporation  at 
24 h  in primary cultures (Fig.  2), 
TGFfl-mediated Hypertrophy Is Dependent on an 
Active Member of the pRB Family 
The above studies  demonstrate that TGF/~l-induced main- 
tenance of active, hypophosphorylated pRB correlates with 
TGF~'I's ability to convert EGF-induced hyperplasia to hy- 
pertrophy. If pRB plays a key role in this process, it would 
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E  abundance  by  EGF  and 
TGF8I.  (A) Western blot on 
NRK-52E  cells. Cells were 
grown and treated as in Fig. 6 
with vehicle alone (C), EGF 
alone (E), TGFB1 alone (T), 
or EGF +  TGFB1 (TE).  (B) 
Effect on EGF and TGF/~I on 
cyclin Eabundance.  The per- 
centage  change in  cyclin  E 
abundance  is  plotted  on  the 
y-axis. 
be predicted that prior inhibition of pRB would prevent the 
development of hypertrophy following exposure to EGF  + 
TGF/31. 
For these  studies  two approaches  were used.  First,  we 
generated several renal cell lines from renal tubule segments 
microdissected from mice transgenic for the SV40 large T 
antigen (Tg[SV40E]Bri7) (1). SV40 large T antigen binds to 
the hypophosphorylated, active form of pRB and two other 
pRB-related proteins (p107 and p130), effectively sequester- 
ing the proteins and rendering them inactive (11, 19, 35). In 
these lines,  SV40 large T  antigen expression was variable 
(Fig. 1  l, solid bars). Therefore, we examined the correlation 
between  SV40  large  T  antigen  expression  and  EGF  + 
TGFl~l-induced hypertrophy. As shown in Fig.  11 there was 
an inverse relationship between expression of SV40 large T 
antigen (solid bars) and the magnitude of  the EGF +  TGF/31- 
induced hypertrophy (open  bars).  The two cell lines with 
highest  large  T  antigen  expression and  least  hypertrophy 
were both of  proximal tubule origin, while the cell lines with 
lowest  large  T  antigen  expression  and  significant  hyper- 
trophy were of collecting tubule origin. Thus, it was possible 
that the key variable that determined whether cells developed 
hypertrophy was  cell type rather than large T  antigen ex- 
pression. 
As a second approach we overexpressed SV40 large T anti- 
gen, which was introduced into NRK-52E cells by retroviral 
infection (see Materials and Methods). We then generated a 
number of clonal cell lines stably expressing the vector con- 
taining the SV40 large T antigen (pZIPNeoSV(X)I). Fig.  12 
a  is a Western blot demonstrating the variability of SV40 
large T  antigen expression in  10 clones infected with the 
pZIPNeoSV(X)I vector. Six of these clones (lanes 1,  4-7, 
and 10), representing the range of SV40 large T antigen ex- 
pression, were selected for further study. Fig. 12 b compares 
the magnitude of hypertrophy as a  function of SV40 large 
T antigen expression in these clones, compared to EGF  + 
TGFBl-induced hypertrophy in cells infected with the vector 
without SV40 large T antigen insert (lane 11 in a; open circle 
in b). As can be seen, SV40 large T antigen expression in- 
hibits hypertrophy, and there is an inverse relationship be- 
tween the magnitude of SV40 large T antigen expression and 
the degree of EGF +  TGFBl-induced hypertrophy. As shown 
by linear regression, the y-intercept is significantly less than 
100%, demonstrating that a small amount of SV40 large T 
antigen expression has a large effect on the development of 
hypertrophy. These results support the hypothesis that active 
pRB or a related family member plays a key role in the devel- 
opment of EGF  +  TGFBl-induced hypertrophy. 
SV40 large T  antigen inactivates pRB, pRB-related pro- 
teins,  and  p53.  To confirm that  the modulation of hyper- 
trophy was secondary to inactivation of a member of the pRB 
family,  and not an effect on p53,  NRK-52E cells were in- 
fected with retroviruses containing either HPV16 E6 (which 
degrades p53), HPV16 E7 (which binds and effectively se- 
questers pRB and pRB-related proteins), or both (8, 24, 48). 
A similar approach has been used in keratinocytes to demon- 
strate  that  TGFB-mediated inhibition  of growth  involves 
regulation  of prB  activity  (44).  EGF  +  TGFBl-induced 
hypertrophy was inhibited in E7 and E6E7 expressing cells, 
but  not  in  the  E6  expressing  cells,  as  assessed  by  pro- 
tein/DNA  ratio  (Fig.  13).  Similar  results  were  obtained 
when cell size was assessed (Fig. 14). These studies provide 
additional support for a role for active pRB or a related fam- 
ily member in TGFB-dependent hypertrophy. 
In the studies in which the family of pRB proteins was in- 
activated, either by SV40 large T antigen or HPV16 E7, inhi- 
bition  of  hypertrophy  was  associated  with  induction  of 
hyperplasia,  assayed  as  DNA  content per  well  (data  not 
shown). This observation provides additional support for a 
hypertrophy model in which the development of hypertrophy 
is the consequence of arresting a hyperplastic process. 
Figure 9. Time course of  the effect  of  EGF on pRB phosphorylation. 
Western blot on primary cultures of proximal tubule cells, pRB is 
the  hypophosphorylated  (active) species of pRB; ppRB is  the 
hyperphosphorylated (inactive) species of pRB. 
Discussion 
Renal hypertrophy occurs in a number of conditions, some 
of which are associated with the development of sclerosis 
The Journal of Cell Biology,  Volume 129, 1995  250 Figure  10.  Regulation of pRB phos- 
phorylation by EGF and TGF/$1. (A) 
Western blot on primary cultures of 
proximal  tubule  cells,  pRB  and 
ppRB defined as in Fig. 9. (B) Effect 
of EGF and TGF/~I on the percent of 
pRB  in  the  hyperphosphorylated 
state. Cells were grown and treated 
as in Fig. 1. The percent of pRB in 
the  hyperphosphorylated  state  is 
plotted on the y-axis. See Materials 
and  Methods  for method  of quan- 
titating pRB. n  =  3.  *  =  P < 0.05 vs. 
control; ** =  P < 0.01 vs. control; + 
=  P  <  0.05 vs. EGF alone. 
and the progressive loss of renal function. R has been postu- 
lated that the hypertrophic process, while possibly beneficial 
initially, elicits responses that over the long term contribute 
to renal destruction (6, 53). Similarly, while cardiac hyper- 
trophy is in some respects beneficial, it too has deleterious 
effects, and is postulated to contribute long term to loss of 
cardiac function (9, 51). In spite of its potential importance 
in renal and cardiovascular disease, the cellular and molecu- 
lar mechanisms responsible for hypertrophy are poorly un- 
derstood. An understanding of these mechanisms can pro- 
vide an initial basis for examining the processes by which 
hypertrophy  may  cause  deleterious  effects  on  renal  and 
cardiac function. 
One  possible mechanism  for the development of hyper- 
trophy is for cells to enter the growth cycle, but not progress 
into S phase. This would result in the synthesis of new cell 
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Figure  I1.  SV40 large T antigen expression and the magnitude of 
the EGF +  TGFBl-induced hypertrophy in cell lines derived from 
a mouse transgenic for SV40 large T antigen. SV40 large T antigen 
expression is plotted as a percent of the highest expressing cell line 
(MPCTI) (solid bars), n  =  3.  +  =  P  <  0.01 vs.  MPCT1.  Cells 
treated for 96 h with EGF (10  -8 M) and TGFB1 (10  -z° M). The ra- 
tio of protein/DNA is plotted as a percent of control values (cells 
treated with vehicles only) (open bars), n  =  18. *  =  P <  0.01 vs. 
untreated cell line. The slope of the regression between SV40 large 
T antigen expression and the protein/DNA ratio was significantly 
different from zero (P < 0.05). MMCD1, mouse medullary collect- 
ing duct cell line 1; MMCD2, mouse medullary collecting  duct cell 
line 2; MPST1, mouse proximal straight tubule cell line 1; MPCT1, 
mouse proximal convoluted tubule cell line 1. 
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Figure  12.  Correlation between EGF  +  TGF~l-induced hyper- 
trophy and the magnitude of SV40  large T  antigen expression of 
NRK-52E clonal lines stably expressing the SV40 large T antigen 
gene. (A) Western blot showing SV40 large T  antigen expression 
in 10 clones (lanes 1-10). Lane//is a cell lysate from control in- 
fected cells (vector plus neomycin resistance gene only). (B) EGF 
+  TGFBl-induced hypertrophy as a function of the magnitude of 
SV40 large T antigen expression in 6 of the 10 clones. Cells were 
treated as in Fig. 11. SV40 large T antigen expression is plotted on 
the x-axis; the increase in protein/DNA in cells infected with pZIP- 
NeoSV(X)I, as a percent of that seen in cells infected with pZIP- 
Neo(X)I (open  circle),  is plottcxt on the y-axis. The slope of the 
regression between the protein/DNA ratio and SV40 large T anti- 
gen expression was significantly different from zero (P <  0.01). n 
=  12 per group for the protein/DNA measurements; n  =  3 for the 
measurement of SV40 large T  antigen expression. 
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Figure 13. Effect of EGF +  TGFBI on the ratio of protein/DNA 
in NRK-52E cells infected with HPV16. Cells were infected with 
HPV16 E6 (E6), HPV16 E7 (E7), or HPV16 E6 and E7 (E6/E7) 
as described in the Materials and Methods section. Cells were 
treated as in Fig. 11. The ratio of protein/DNA is plotted on the 
y-axis as a percent of EGF + TGFBl-induced  hypertrophy in con- 
trol infected cells, n  =  12 per group. * =  P < 0.01 vs. vector. 
proteins, but would prevent DNA synthesis and subsequent 
cell division. To address whether this is a feasible model for 
renal tubular hypertrophy, we treated primary cultures of 
proximal tubule cells with EGF, a growth factor known to 
induce proximal tubule cells to enter the growth cycle, and 
TGFB1, a cytokine known to inhibit growth in many cells by 
Gt/S  blockade.  EGF alone increased DNA synthesis and 
DNA content/well and stimulated protein synthesis, without 
affecting the ratio of cell protein/DNA.  TGFB1 alone in- 
hibited DNA synthesis, reduced DNA content/well, and had 
no effect on protein synthesis. The lack of an effect on basal 
protein synthesis coupled with a decrease in DNA synthesis 
is  responsible  for the small increase in the ratio of pro- 
Figure 14. Effect of EGF + TGFB1 on mean forward light scatter 
in HPV16 E7 infected  cells. Cells were rendered quiescent for 48 h 
and then treated with vehicle (LXSN and E7) or the combination 
of EGF + TGFBI (LSXN-TE  and E7-TE) for 48 h before study. For 
each group mean forward light scatter is plotted on the y-axis as 
a percent of control. LXSN, infected with vector alone; E7, in- 
fected with HPV16 E7. 
tein/DNA that was observed. However,  the combination of 
TGF~ and EGF resulted in the development of  hypertrophy. 
The present results are consistent with the role of TGF/~ 
in other models of  hypertrophy. In primary cultures of  vascu- 
lar  smooth muscle,  TGF/~ is  associated  with  significant 
hypertrophy in the presence of serum, but with only minimal 
hypertrophy in the absence of serum (42).  In primary cul- 
tures of  rabbit proximal tubule cells, TGFB converted insulin 
plus  hydrocortisone-mediated hyperplasia to  hypertrophy 
(12). Autocrine effects of secreted TGF/~ appear to mediate 
angiotensin R-induced hypertrophy in mouse cortical tubule 
(MCT, a renal cell line) and vascular smooth muscle cells, 
and glucose-induced hypertrophy in MCT and mesangial 
ceils,  in  that  TGFB  neutralizing  antibodies  convert  the 
hypertrophy to hyperplasia (17, 46, 52). Thus, TGF/~-medi- 
ated  inhibition of hyperplasia plays an  important role  in 
the  development  of  hypertrophy  in  many  experimental 
models. 
Our results suggest that the conversion of EGF-induced 
hyperplasia to hypertrophy by TGFB is mediated through 
regulation of the pRB family of proteins.  TGF/~ inhibited 
EGF-induced pRB hyperphosphorylation, thus maintaining 
pRB in its active form. To address the role of pRB in the 
development of hypertrophy, we examined the effect of in- 
hibiting pRB.  In  cells  expressing  SV40  large  T  antigen, 
hypertrophy was inhibited, and the degree of hypertrophy 
correlated inversely with large T  antigen expression.  Be- 
cause SV40 large T antigen binds a number of nuclear pro- 
teins,  including pRB,  pRB-related  proteins,  and  p53,  we 
used a second approach. In cells infected with HPV16  E7, 
which  inactivates pRB  and  pRB-related  proteins,  hyper- 
trophy  was  inhibited.  Conversely  in  cells  infected  with 
HPV16  E6,  which  degrades  p53,  hypertrophy was  unaf- 
fected. It also remains possible that another protein that can 
be inactivated by both SV40 large T antigen and HPV16 E7, 
but not HPV16 E6, is part of the signaling pathway in TGF~- 
dependent hypertrophy. 
These studies agree with the important role that main- 
tenance of an active member of the pRB family plays in the 
antiproliferative effects of TGF/3. In ceils in which TGFB is 
growth suppressive this effect is mediated by G~/S block- 
ade, is accompanied by inhibition of pRB phosphorylation, 
and is inhibited by SV40 large T antigen (15, 23,  32, 44). 
An unresolved major question is the mechanism by which 
pRB phosphorylation is inhibited by TGF/3. pRB is phos- 
phorylated  by  G~  cyclin-dependent kinases,  likely either 
cdk4/cyclin D or cdk2/cyclin E kinases. The activity of these 
kinases can be regulated by the abundance of either the cdk 
or cyclin molecule,  the ability of the respective  cdk and 
cyclin to form a stable complex, the rate ofcdk phosphoryla- 
tion,  and/or the  presence  of cyclin-dependent kinase  in- 
hibitors, particularly p21,  p27 K~P~, and p15 ~sK4B. In TGFB- 
induced  arrest  of hyperplasia,  TGFB prevents  the  stable 
assembly of and/or activation of cdk2/cyclin E (28). In addi- 
tion,  TGFB reduces cyclins E  and A  mRNA and protein 
abundance, inhibits cdk2 and cdk4 synthesis, and increases 
p15  ls~4~ abundance,  all  of which  can  secondarily inhibit 
cdk2/cyclin E activity (10, 16, 18, 43). The role of these ki- 
nases in hypertrophy remains to be defined. 
In  summary,  TGF/3 converts  EGF-induced hyperplasia 
into hypertrophy by inhibiting progression from Gl  to  S 
phase. Inhibition of pRB phosphorylation and maintenance 
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significant role in this effect. Blockade at the GdS transi- 
tion in this model is TGFl3-dependent,  but may be mediated 
in in vivo hypertrophy by other cytokines, by contact inhibi- 
tion or by terminal  differentiation,  as in cardiac  myocytes. 
The pRB family of proteins may play  an important  role in 
some or all of these processes. Evidence that cells enter the 
growth  cycle  in  in  vivo  models  of hypertrophy  has  been 
provided by demonstrated increases in immediate early gene 
expression in cardiac and renal hypertrophy  (25, 29, 38, 47, 
50).  However, this effect can be somewhat nonspecific, and 
results  in renal  hypertrophy  have  not been consistent (40, 
41). The present studies raise the possibility that the sclerosis 
and disease progression seen in hypertrophy may be second- 
ary to signals generated  by persistently activated  pRB or a 
related protein, possibly in combination with other G~ sig- 
naling events. 
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